Medicinal composition for treating pulpitis

Abstract

The invention discloses a medicinal composition for treating pulpitis. The medicinal composition is prepared from the following medicinal materials in parts by weight: 20-40 parts of nicotinic acid, 10-20 parts of dibazolum, 1-3 parts of chlortrimeton, 0.5-1.5 parts of hexadecadrol, 15-30 parts of phenytoin sodium, 5-10 parts of vitamin, and 200-400 parts of metronidazole. According to the medicine, the components have good synergistic effects, so that the effects of the medicine for resisting inflammation and histamine and inhibiting anaerobic bacteria are obviously enhanced, and meanwhile, the medicine also has the good analgesic effect, and enables edema and inflammation of the pulp tissue to be rapidly controlled and eliminated, so that the pressure inside the dental pulp cavity of a patient is rapidly alleviated, and further, the pain of the patient is alleviated. The medicine is suitable for treating acute pulpitis and apical periodontitis, and also has good curative effects for supraorbital neuralgia and cerebrovascular tension increased type migraine.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to view more

AI Technical Summary

Benefits of technology

The technical effects described in this patented pharmaceuticals include improving their ability to fight against diseases such as pneumonia (including common ones), bleeding from teeth, and rheumatoid arthritis (RA). They work together through different mechanisms like stimulating blood flow, reducing swelling, promoting healing processes, controlling pain relief over longer periods without causing discomfort. These treatments help reduce these issues while still being able to provide quick results when needed again.

Problems solved by technology

This patented technical problem addressed by this patents involves finding ways for reducing swelling caused from bleeding between teeth due to periodontium disease without causing significant damage during therapy procedures such as cleaning them off.